Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12001961Phase 3Completed
Phase 3, double-blind trial of perindopril and perindopril tert-butylamine in essential hypertension (2 arms), sponsored by Servier. Primary endpoint: Change from baseline to week 8 in sitting systolic blood pressure. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12001961.